Børge Nordestgaard: Lp(a) Remains a Risk Factor Across the Lifespan
Børge Nordestgaard, Professor and Chief Physician at Herlev og Gentofte Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation, adding:
”In a contemporary primary prevention cohort (Copenhagen General Populatuion Study), the relative risk increase of ASCVD with higher Lp(a) levels was similar for individuals aged older (aged 70–100 years) and younger (aged 20-69 years) individuals, with the highest absolute risk in this older age group.
Written by Janeni Jeevanathan, Peter E. Thomas, Pia R. Kamstrup, and Børge Nordestgaard, and published in Circulation with simultaneous presentation at the 2026 ESC Congress in Munich yesterday.”
Title: Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years
Authors: Janeni Jeevanathan, Peter E. Thomas, Pia R. Kamstrup, Børge G. Nordestgaard
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning